History, challenges and perspectives of cell microencapsulation

Trends in Biotechnology

Volumn 22, Issue 2, 2004, Pages 87-92

  Orive, Gorka ^a   Hernández, Rose Maria ^a   Rodríguez Gascón, Alicia ^a   Calafiore, Riccardo ^b   Chang, Thomas Ming Swi ^c   De Vos, Paul ^d   Hortelano, Gonzalo ^e   Hunkeler, David ^f   Lacík, Igor ^g   Pedraz, José Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF PERUGIA   (Italy)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MCMASTER UNIVERSITY   (Canada)

^f AQUA+TECH Specialties SA   (Switzerland)

^g POLYMER INSTITUTE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DISEASES; MEDICINE;

THERAPEUTIC PRODUCTS;

CELLS;

ALGINIC ACID; AMMONIUM DERIVATIVE; BIOMATERIAL; CANCER VACCINE; CELLULOSE SULFATE; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 2B1; CYTOKINE; CYTOTOXIC AGENT; HLA ANTIGEN; HORMONE; IMMUNOSUPPRESSIVE AGENT; NEUROTROPHIC FACTOR; POLYANION; POLYDIALLYLDIMETHYLAMMONIUM CHLORIDE; POLYLYSINE; POLYMACON; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

BIOTECHNOLOGY;

ADOPTIVE IMMUNOTHERAPY; ADRENAL CELL; ALLOGRAFT; ALLOTRANSPLANTATION; ANTIBODY PRODUCTION; ARTIFICIAL ORGAN; BIOCOMPATIBILITY; BIOTECHNOLOGY; CANCER; CELL BASED GENE THERAPY; CELL LINE; CHRONIC PAIN; COST EFFECTIVENESS ANALYSIS; DEVICE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; ENZYME IMMOBILIZATION; EPILEPSY; FABRY DISEASE; GRAFT REJECTION; HEALTH INSURANCE; HEMOPHILIA; HOMEOSTASIS; HORMONE SUBSTITUTION; HUMAN; IMMOBILIZED CELL; IMMUNE SYSTEM; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MICROCAPSULE; MICROENCAPSULATION; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS CANCER; PARATHYROID DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; XENOGRAFT;

UNIDENTIFIED RETROVIRUS;

EID: 9144263544     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2003.11.004     Document Type: Review

References (44)

1. Bisceglie V. Uber die antineoplastische immunitat; heterologe Einpflnzung von Tumoren in Huhner-embryonen. Ztschr. Krebsforsch. 40:1933;122-140.
2. Chang T.M.S. Semipermeable microcapsules. Science. 146:1964;524-525.
3. Chick W.L., et al. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science. 187:1975;847-848.
4. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-909.
5. Prakash S., Chang T.M.S. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2:1996;883-887.
6. Sun Y.L., et al. Normalization of diabetes in spontaneously diabetic cynomologous monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98:1996;1417-1422.
7. Hortelano G., et al. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:1996;5095-5103.
8. Soon-Shiong P., et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet. 343:1994;950-951.
9. Löhr M., et al. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet. 357:2001;1591-1592.
10. Orive G., et al. Cell encapsulation: promise and progress. Nat. Med. 9:2003;104-107.
11. Lanza R.P., et al. Encapsulated cell technology. Nat. Biotechnol. 14:1996;1107-1111.
12. Shapiro A.M.J., et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:2000;230-238.
13. Lanza R.P., et al. Human therapeutic cloning. Nat. Med. 5:1999;975-977.
14. Klöck G., et al. Biocompatibility of mannuronic acid-rich alginates. Biomaterials. 18:1997;707-713.
15. King A., et al. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J. Biomed. Mater. Res. 64:2003;533-539.
16. Strand B.L., et al. Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 10:2001;263-275.
17. Duvivier-Kali V.F., et al. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes. 50:2001;1698-1705.
18. Thu B., et al. Alginate polycation microcapsules. II. Some functional properties. Biomaterials. 17:1996;1069-1079.
19. Schuldt U., Hunkeler D. Characterization methods for microcapsules. Minerva Biotec. 12:2000;249-264.
20. Uludag H., et al. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42:2000;29-64.
21. De Vos P., et al. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia. 45:2002;159-173.
22. Rafael E., et al. In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: a novel application of the microdialysis technique. Cell Transplant. 8:1999;317-326.
23. Sharkawy A.A., et al. Engineering the tissue which encapsulates subcutaneous implants. Diffusion properties. J. Biomed. Mater. Res. 37:1997;401-412.
24. Hunkeler D., et al. Objectively assessing bioartificial organs. Ann. N. Y. Acad. Sci. 944:2001;456-471.
25. Calafiore R., et al. Transplantation of minimal volume microcapsules in diabetic high mammalians. Ann. N. Y. Acad. Sci. 875:1999;219-232.
26. Wang T., et al. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15:1997;358-362.
27. Mares-Guia, M. and Ricordi, C. Hetero-polysaccharide conjugate and methods of making and using the same. US Patent 6,281,341.
28. Orive G., et al. Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation. Int. J. Pharm. 259:2003;57-68.
29. Sakai S., et al. Synthesis and transport characterization of alginate/aminopropyl-silicate/alginate microcapsule: application to bioartificial pancreas. Biomaterials. 22:2001;2827-2834.
30. Luca G., et al. Multifunctional microcapsules for pancreatic islet cell entrapment: design, preparation and in vitro characterization. Biomaterials. 24:2003;31091-31114.
31. Chang P.L., Bowie K.M.M. Development of engineered cells for implantation in gene therapy. Adv. Drug Deliv. Rev. 33:1998;31-43.
32. Murphy F.A. The public health risk of animal organ and tissue transplantation into humans. Science. 273:1996;746-747.
33. De Vos P., Marchetti P. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. 8:2002;363-366.
34. Hasse C., et al. Parathyroid allotransplantation without immunosuppression. Lancet. 350:1997;1296-1297.
35. Löhr M., et al. Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Cancer Chemother. Pharmacol. 49:(Suppl. 1):2002;S21-S24.
36. Saller R.M., et al. Encapsulated cells producing retroviral vectors for in vivo gene transfer. J. Gene Med. 4:2002;150-160.
37. Tse M., et al. Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules. Biotechnol. Bioeng. 51:1996;271-280.
38. Iwata H., et al. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J. Biomed. Mater. Res. 28:1994;1201-1207.
39. Orive G., et al. Microencapsulation of an anti VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol. Bioeng. 76:2001;285-294.
40. Zekorn T., et al. Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Transplant. Proc. 24:1992;937-939.
41. Dautzenberg H., et al. Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann. N. Y. Acad. Sci. 875:1999;46-63.
42. Bartkowiak A., Hunkeler D. New microcapsules based on oligoelectrolyte complexation. Ann. N. Y. Acad. Sci. 875:1999;36-45.
43. Iwata H., et al. The use of photocrosslinkable polyvinyl alcohol in the immunoisolation of pancreatic islets. Transplant. Proc. 22:1990;797-799.
44. Cruise G.M., et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 8:1999;293-306.